OpenAI plans to file confidentially with the SEC this summer and go public by September 2026, marking one of the fastest transitions from private AI startup to public company. Valued between $80 billion and $90 billion, the company’s IPO could be the most significant tech offering since Arm Holdings in 2023. OpenAI’s unique capped-profit structure limits investor returns, with excess profits supporting its nonprofit mission. The IPO will test market appetite for AI software firms amid rising competition and could influence future AI-related public listings, especially as SpaceX’s IPO looms as a competing event.
SpaceX is choosing to focus on long-term growth rather than immediate profitability, similar to Amazon's approach in its early years. Experts say SpaceX could be profitable now if it reduced spending on projects like Starship and AI infrastructure, b...
Cornerstone has released an updated version of the EPA's GHG Emission Factors Hub, providing free, consolidated data for scopes 1, 2, and 3 greenhouse gas emissions. This update includes new factors for air travel, refrigerants, and aligns with the l...
Lyell Immunopharma presented updated safety and translational data for its CAR T-cell therapy, ronde-cel, in treating relapsed or refractory large B-cell lymphoma (LBCL). Over 100 patients treated showed no severe cytokine release syndrome (CRS) and ...
Ascendis Pharma reported positive five-year results from its Phase 2 PaTH Forward trial of TransCon PTH (palopegteriparatide) for adult hypoparathyroidism. The therapy maintained stable calcium levels, kidney and bone health, and quality of life, all...
SpaceX began trading on the stock market at $150 per share, above its IPO price of $135, marking the largest public offering in history and valuing the company at about $1.96 trillion. The shares quickly rose to $165, reflecting strong demand that ex...
